Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1987 1
1990 1
1991 3
1992 2
1993 3
1994 5
1995 7
1996 6
1997 9
1998 10
1999 7
2000 13
2001 16
2002 10
2003 19
2004 15
2005 17
2006 10
2007 18
2008 14
2009 17
2010 12
2011 18
2012 17
2013 15
2014 16
2015 11
2016 15
2017 9
2018 11
2019 9
2020 10
2021 7
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Results by year

Filters applied: . Clear all
Page 1
Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children.
Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, Butalia S, Leung AA, Harris KC, Cloutier L, Zarnke KB, Ruzicka M, Hiremath S, Feldman RD, Tobe SW, Campbell TS, Bacon SL, Nerenberg KA, Dresser GK, Fournier A, Burgess E, Lindsay P, Rabkin SW, Prebtani APH, Grover S, Honos G, Alfonsi JE, Arcand J, Audibert F, Benoit G, Bittman J, Bolli P, Côté AM, Dionne J, Don-Wauchope A, Edwards C, Firoz T, Gabor JY, Gilbert RE, Grégoire JC, Gryn SE, Gupta M, Hannah-Shmouni F, Hegele RA, Herman RJ, Hill MD, Howlett JG, Hundemer GL, Jones C, Kaczorowski J, Khan NA, Kuyper LM, Lamarre-Cliche M, Lavoie KL, Leiter LA, Lewanczuk R, Logan AG, Magee LA, Mangat BK, McFarlane PA, McLean D, Michaud A, Milot A, Moe GW, Penner SB, Pipe A, Poppe AY, Rey E, Roerecke M, Schiffrin EL, Selby P, Sharma M, Shoamanesh A, Sivapalan P, Townsend RR, Tran K, Trudeau L, Tsuyuki RT, Vallée M, Woo V, Bell AD, Daskalopoulou SS. Rabi DM, et al. Among authors: gilbert re. Can J Cardiol. 2020 May;36(5):596-624. doi: 10.1016/j.cjca.2020.02.086. Can J Cardiol. 2020. PMID: 32389335 Review.
Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
Mazer CD, Hare GMT, Connelly PW, Gilbert RE, Shehata N, Quan A, Teoh H, Leiter LA, Zinman B, Jüni P, Zuo F, Mistry N, Thorpe KE, Goldenberg RM, Yan AT, Connelly KA, Verma S. Mazer CD, et al. Among authors: gilbert re. Circulation. 2020 Feb 25;141(8):704-707. doi: 10.1161/CIRCULATIONAHA.119.044235. Epub 2019 Nov 11. Circulation. 2020. PMID: 31707794 No abstract available.
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H, Zuo F, Quan A, Farkouh ME, Fitchett DH, Goodman SG, Goldenberg RM, Al-Omran M, Gilbert RE, Bhatt DL, Leiter LA, Jüni P, Zinman B, Connelly KA. Verma S, et al. Among authors: gilbert re. Circulation. 2019 Nov 19;140(21):1693-1702. doi: 10.1161/CIRCULATIONAHA.119.042375. Epub 2019 Aug 22. Circulation. 2019. PMID: 31434508 Clinical Trial.
Diabetic vascular complications.
Cooper ME, Gilbert RE, Jerums G. Cooper ME, et al. Among authors: gilbert re. Clin Exp Pharmacol Physiol. 1997 Sep-Oct;24(9-10):770-5. doi: 10.1111/j.1440-1681.1997.tb02130.x. Clin Exp Pharmacol Physiol. 1997. PMID: 9315387 Review.
Treatment of Hypertension.
Diabetes Canada Clinical Practice Guidelines Expert Committee; Tobe SW, Gilbert RE, Jones C, Leiter LA, Prebtani APH, Woo V. Diabetes Canada Clinical Practice Guidelines Expert Committee, et al. Among authors: gilbert re. Can J Diabetes. 2018 Apr;42 Suppl 1:S186-S189. doi: 10.1016/j.jcjd.2017.10.011. Can J Diabetes. 2018. PMID: 29650094 No abstract available.
Understanding EMPA-REG OUTCOME.
Gilbert RE, Connelly KA. Gilbert RE, et al. Lancet Diabetes Endocrinol. 2015 Dec;3(12):930-1. doi: 10.1016/S2213-8587(15)00427-1. Lancet Diabetes Endocrinol. 2015. PMID: 26590681 No abstract available.
The endothelium in diabetic nephropathy.
Gilbert RE. Gilbert RE. Curr Atheroscler Rep. 2014 May;16(5):410. doi: 10.1007/s11883-014-0410-8. Curr Atheroscler Rep. 2014. PMID: 24623181 Review.
The endothelium in diabetic nephropathy.
Advani A, Gilbert RE. Advani A, et al. Among authors: gilbert re. Semin Nephrol. 2012 Mar;32(2):199-207. doi: 10.1016/j.semnephrol.2012.02.006. Semin Nephrol. 2012. PMID: 22617769 Review.
Hypertension revisited.
Campbell NR, Gilbert RE, Leiter LA, Larochelle P, Tobe S, Chockalingam A, Ward R, Morris D, Tsuyuki RT, Harris S. Campbell NR, et al. Among authors: gilbert re. Can Fam Physician. 2012 Jun;58(6):634-6. Can Fam Physician. 2012. PMID: 22700731 Free PMC article. No abstract available.
Finerenone in diabetic kidney disease - So far, so good.
Gilbert RE. Gilbert RE. J Diabetes Complications. 2017 Apr;31(4):651-652. doi: 10.1016/j.jdiacomp.2016.12.012. Epub 2017 Jan 20. J Diabetes Complications. 2017. PMID: 28153675 No abstract available.
338 results